Cardioloxía
Servicio
University of Copenhagen
Copenhague, DinamarcaPublicacións en colaboración con investigadores/as de University of Copenhagen (22)
2024
-
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American Heart Association, Vol. 13, Núm. 15, pp. e035993
-
European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance
Transplant International , Vol. 37
2023
-
Donor heart selection: Evidence-based guidelines for providers
Journal of Heart and Lung Transplantation, Vol. 42, Núm. 1, pp. 7-29
2022
-
Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies
European heart journal, Vol. 43, Núm. 23, pp. 2237-2246
-
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology
European Journal of Heart Failure, Vol. 24, Núm. 1, pp. 143-168
-
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology
European journal of preventive cardiology, Vol. 29, Núm. 1, pp. 275-300
2021
-
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116
-
Efficacy of the COVID-19 vaccine in heart transplant recipients: what we know and what we ignore
European Journal of Heart Failure
-
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry
ESC Heart Failure, Vol. 8, Núm. 6, pp. 4955-4967
-
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199
2020
-
Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
Atherosclerosis, Vol. 312, pp. 79-89
-
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171
-
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
Advances in Therapy, Vol. 37, Núm. 5, pp. 1724-1736
2019
-
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
International Journal of Cardiology, Vol. 297, pp. 83-90
-
Effects of serelaxin in patients with acute heart failure
New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726
-
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry
Journal of the American Heart Association, Vol. 8, Núm. 3
2018
-
Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control
Heart Rhythm, Vol. 15, Núm. 12, pp. 1800-1807
2017
-
Comparison of everolimus-eluting bioresorbable scaffolds with everolimuseluting metallic stents for treatment of coronary artery stenosis: Three-year follow-up of the ABSORB II randomized trial
Bioresorbable Scaffolds: From Basic Concept to Clinical Applications (CRC Press), pp. 224-237
2016
-
A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly: Design of the EU-CaRE randomised controlled trial
European Journal of Preventive Cardiology, Vol. 23, Núm. 2_suppl, pp. 27-40
-
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
The Lancet, Vol. 388, Núm. 10059, pp. 2479-2491